Tracking change in rod, cone, and RPE mosaics independently in geographic atrophy
Tracking change in rod, cone, and RPE mosaics independently in geographic atrophy
批准号:
8202713
负责人:
Ethan A Rossi
金额:
$4.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2012-08-31
关键词:
AffectAgeAge related macular degenerationAgingAging-Related ProcessAmericanAreaAtrophicBlindnessCell DensityCell ShapeCell SizeCellsClinicalComplexDensitometryDiseaseDisease ProgressionEtiologyEvolutionExudative age-related macular degenerationEyeFellowshipFunctional disorderGoalsHumanImageImaging technologyIndividualLifeLightLongitudinal StudiesMeasuresMethodsMicroscopicMonitorMorphologyOpticsOutcome MeasurePatientsPatternPhotoreceptorsPlayPopulationPreparationPriceResolutionRetinaRetinalRetinal ConeRetinal DegenerationRoleStagingStructureStructure of retinal pigment epitheliumTestingTherapeutic InterventionTimeTranslatingVertebrate PhotoreceptorsVisionVisual impairmentWorkadaptive opticscell motilitycell typedesignfovea centralisgeographic atrophyimaging modalityin vivoinsightnormal agingoptical imagingpreventretinal rodstheoriestherapy developmenttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Age-related macular degeneration is the most common cause of severe visual impairment in individuals over the age of fifty-five (Adler, Curcio, Hicks, Price, & Wong, 1999; Friedman et al., 2004). Geographic atrophy is an advanced stage of age-related macular degeneration that currently has no treatment. As the US population ages over the next decade, the number of individuals with geographic atrophy is expected to increase by fifty percent (Friedman et al., 2004). The cause of the disease is not understood, which is impeding the development of treatments for it. Several cell types in the retina have been implicated in geographic atrophy, but it is impossible to examine the microscopic changes that these cells undergo in the living human eye using current clinical tools. High resolution retinal imaging methods, which use adaptive optics, a method for measuring and correcting the optical aberrations present in all eyes, allow for microscopic examination of individual cells in the living human retina. The objective of this project is to apply high resolution retinal imaging with adaptive optics to geographic atrophy patients to simultaneously image three independent cell mosaics in the retina: cones, rods and retinal pigment epithelium, and to track them as the disease progresses. High resolution retinal imaging of the light sensitive rod and cone photoreceptors and of the retinal pigment epithelium (another retinal cell type that is critical to vision) will allow us to see microscopic changes due to geographic atrophy that have never before been seen in the living human eye. This project will provide insight into how geographic atrophy progresses through these cell types, including the sequence of cell loss, which will allow us to discriminate between different competing theories regarding the origin of geographic atrophy. This understanding will be critical for targeting therapeutic interventions for geographic atrophy to the appropriate cell type. Not only may the application of adaptive optics imaging methods allow us to discriminate between different theories of geographic atrophy, it may also provide a way to detect the disease earlier in its time-course and eventually may provide a valuable outcome measure for the development of therapies for geographic atrophy. [Using high resolution retinal densitometry in AOSLO, we will assess changes in photoreceptor function that accompany structural changes in geographic atrophy.]
PUBLIC HEALTH RELEVANCE: Geographic atrophy is an advanced stage of age-related macular degeneration, a disease that is the most common cause of severe visual impairment in individuals over the age of fifty-five. This project aims to develop a comprehensive understanding of the origin of geographic atrophy and its progression by using advanced imaging methods to see how different cells in the eye are changed as a result of disease. This understanding is critical for the development of treatments for geographic atrophy, a disease that is expected to affect more Americans as the population ages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Distinguishing normal aging from age-related macular degeneration at the level of single cells int eh living human eye
-
批准号:10172913
-
项目类别:
-
资助金额:$52.43万
-
财政年份:2020
-
负责人:Ethan A Rossi
-
依托单位:
Distinguishing normal aging from age-related macular degeneration at the level of single cells in the living human eye
-
批准号:10652451
-
项目类别:
-
资助金额:$44.45万
-
财政年份:2020
-
负责人:Ethan A Rossi
-
依托单位:
Distinguishing normal aging from age-related macular degeneration at the level of single cells int eh living human eye
-
批准号:9973645
-
项目类别:
-
资助金额:$52.7万
-
财政年份:2020
-
负责人:Ethan A Rossi
-
依托单位:
Distinguishing normal aging from age-related macular degeneration at the level of single cells in the living human eye
-
批准号:10413037
-
项目类别:
-
资助金额:$49.95万
-
财政年份:2020
-
负责人:Ethan A Rossi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: